Argenx (NASDAQ: ARGX) has been upgraded to an "outperform" rating from "underperform" by Bernstein, with the price target revised sharply upwards to €755 from 1 ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...

Here is a look at the NEET UG 2025 syllabus and answers to frequently asked questions regarding the Biology subject.